Latest News & Features
Big Pharma
Biotech company Illumina has asked a Delaware court to overturn a finding that it willfully infringed two DNA sequencing patents and must pay $334 million in damages. 6 June 2022
Big Pharma
GlaxoSmithKline has agreed to acquire Affinivax, a clinical-stage biopharmaceutical company based in Cambridge, Boston and focusing on developing vaccines. 1 June 2022
Americas
Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada. 31 May 2022
Big Pharma
Pfizer has announced that it will provide all of its current and future patent-protected medicines and vaccines—that are available in the US or EU—on a not-for-profit basis to 45 lower-income countries. 31 May 2022
Generics
Why does Japan have no reverse payments culture? Takanori Abe of Abe & Partners unpicks a complex issue. 27 May 2022
Genetics
UK legislation to streamline gene-editing technology research is promising for innovation, but presents potential complications for IP, finds Sarah Speight. 26 May 2022
Big Pharma
The UK Supreme Court has ruled that regulators such as the Competition and Markets Authority should be required to pay the costs of a party successfully appealing against one of their infringement decisions. 26 May 2022
Europe
The case reinforced the need for interim injunction applications to be made as quickly as possible, explains Lydia Birch of EIP. 26 May 2022
Asia-Pacific
The Federal Court of Australia has refused an appeal request in a decade-long case brought by Boehringer Ingelheim Animal Health against MSD subsidiary, Intervet International. 24 May 2022
Genetics
OptraHealth has filed a patent infringement lawsuit against Invitae that centres on the latter’s Gia chatbot that offers genetic testing and advice. 24 May 2022